Amphotericin B: new life for an old drug (Q41334774)

29 September 2017

1 reference

title

Amphotericin B: new life for an old drug (English)

1 reference

29 September 2017

1 reference

Hartsel S

1

1 reference

29 September 2017

Bolard J

series ordinal

2

1 reference

29 September 2017

publication date

1 December 1996

1 reference

Trends in Pharmacological Sciences

29 September 2017

published in

1 reference

29 September 2017

volume

17

1 reference

29 September 2017

issue

12

1 reference

29 September 2017

page(s)

445-449

1 reference

Carpal tunnel syndrome and pancytopenia in a 63-year-old woman

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

How do the polyene macrolide antibiotics affect the cellular membrane properties?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Amphotericin B and its delivery by liposomal and lipid formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Clinical use of liposomal and lipid-complexed amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Comparative internalization and recycling of different amphotericin B formulations by a macrophage-like cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

The treatment of American (mucocutaneous) leishmaniasis with amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Development and characterization of a rapid screening assay for identifying antipneumocystis agents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Inhibition of HIV replication by liposomal encapsulated amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Inhibition of HIV-1 Replication in H9 Cells by Nystatin-A Compared with Other Antiviral Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Pharmacological studies of a new derivative of amphotericin B, MS-8209, in mouse and hamster scrapie.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Failure to ameliorate Creutzfeldt-Jakob disease with amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Immunomodulating activity of antifungal drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. 3. Molecular structure of the polyene antibiotic-cholesterol complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

The structure and function of amphotericin B-cholesterol pores in lipid bilayer membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

A sequential mechanism for the formation of aqueous channels by amphotericin B in liposomes. The effect of sterols and phospholipid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Temperature effects on the aggregation state and activity of amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Interaction of plasma proteins and lipoproteins with amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

The interaction of liposomal amphotericin B and serum lipoproteins within the biological milieu

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Effects of the aggregation state of amphotericin B on its toxicity to mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Modification of amphotericin B's therapeutic index by increasing its association with serum high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Amphotericin B methyl ester hydrochloride and amphotericin B: comparative acute toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Leukoencephalopathy in patients treated with amphotericin B methyl ester

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Comparative neurotoxicities of amphotericin B and its mono-methyl ester derivative in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

Amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901012-7

7 January 2021

10.1016/S0165-6147(96)01012-7

Identifiers

DOI

1 reference

29 September 2017

1 reference